DK1212311T3 - Chalconcumariner - Google Patents

Chalconcumariner

Info

Publication number
DK1212311T3
DK1212311T3 DK00965902T DK00965902T DK1212311T3 DK 1212311 T3 DK1212311 T3 DK 1212311T3 DK 00965902 T DK00965902 T DK 00965902T DK 00965902 T DK00965902 T DK 00965902T DK 1212311 T3 DK1212311 T3 DK 1212311T3
Authority
DK
Denmark
Prior art keywords
cell growth
agents
chalconcumariner
hydroxyphenyllactate
antitumor
Prior art date
Application number
DK00965902T
Other languages
Danish (da)
English (en)
Inventor
Ezio Bombardelli
Piero Valenti
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1212311T3 publication Critical patent/DK1212311T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
    • C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
    • C07D311/18—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted otherwise than in position 3 or 7
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Glass Compositions (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Saccharide Compounds (AREA)
  • Fire-Extinguishing Compositions (AREA)
  • Epoxy Compounds (AREA)
DK00965902T 1999-09-03 2000-08-28 Chalconcumariner DK1212311T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9920908.2A GB9920908D0 (en) 1999-09-03 1999-09-03 Chalcone coumarins
PCT/EP2000/008367 WO2001017984A1 (en) 1999-09-03 2000-08-28 Chalcone coumarins

Publications (1)

Publication Number Publication Date
DK1212311T3 true DK1212311T3 (da) 2003-06-23

Family

ID=10860344

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00965902T DK1212311T3 (da) 1999-09-03 2000-08-28 Chalconcumariner

Country Status (22)

Country Link
US (1) US6767916B2 (pl)
EP (1) EP1212311B1 (pl)
JP (1) JP2003508523A (pl)
KR (1) KR100819574B1 (pl)
CN (1) CN1142927C (pl)
AT (1) ATE235480T1 (pl)
AU (1) AU775083B2 (pl)
CA (1) CA2382112A1 (pl)
CZ (1) CZ2002786A3 (pl)
DE (1) DE60001850T2 (pl)
DK (1) DK1212311T3 (pl)
ES (1) ES2191643T3 (pl)
GB (1) GB9920908D0 (pl)
HK (1) HK1043997B (pl)
HU (1) HUP0202581A3 (pl)
NO (1) NO20021048L (pl)
PL (1) PL353245A1 (pl)
PT (1) PT1212311E (pl)
RU (1) RU2266291C2 (pl)
SE (1) SE1212311T5 (pl)
SK (1) SK3102002A3 (pl)
WO (1) WO2001017984A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030229136A1 (en) 2002-04-18 2003-12-11 Nurulain Zaveri Novel flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US7638554B2 (en) 2002-04-18 2009-12-29 Sri International Flavanoids as chemotherapeutic, chemopreventive, and antiangiogenic agents
US8067461B2 (en) 2005-06-08 2011-11-29 Temple University-Of The Commonwealth System Of Higher Education 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof
CN101041646B (zh) * 2007-04-30 2011-07-20 浙江大学 含氮查耳酮衍生物的制备方法和用途
CN101121706B (zh) * 2007-09-18 2010-11-24 南京中瑞药业有限公司 一种香豆素衍生物及其制备方法和用途
WO2009060835A1 (ja) * 2007-11-05 2009-05-14 Kyoto University 新規ユビキリン結合性小分子
WO2012017454A1 (en) 2010-08-05 2012-02-09 Council Of Scientific & Industrial Research Coumarin-chalcones as anticancer agents
EP3333153A1 (en) 2011-06-15 2018-06-13 The U.S.A. as represented by the Secretary, Department of Health and Human Services Nuclear receptor modulators and their use for the treatment and prevention of cancer
CN104987328A (zh) * 2012-05-23 2015-10-21 复旦大学 7-氧、硫或氮杂取代香豆素及其衍生物和用途
CN102731457A (zh) * 2012-06-25 2012-10-17 西南石油大学 一种水溶性荧光示踪聚合物及其制备方法
WO2019096397A1 (en) * 2017-11-16 2019-05-23 The Institute Of Cancer Research: Royal Cancer Hospital Coumarin derivative for therapy or prophylaxis of a cell proliferative disorder
CN109293616B (zh) * 2018-09-29 2022-06-21 贵州大学 一种含香豆素查尔酮类衍生物、其制备方法及应用
JP2022547358A (ja) 2019-09-13 2022-11-14 ジ インスティテュート オブ キャンサー リサーチ：ロイヤル キャンサー ホスピタル 治療組成物、組み合わせ、及び使用方法
US11873296B2 (en) 2022-06-07 2024-01-16 Verastem, Inc. Solid forms of a dual RAF/MEK inhibitor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2387956A1 (fr) * 1977-04-20 1978-11-17 Unicler Derives de la pyridine et leur preparation
US5399561A (en) * 1989-09-19 1995-03-21 Allergan, Inc. Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity
US5023341A (en) * 1989-09-19 1991-06-11 Allergan, Inc. Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity
JPH05509078A (ja) * 1990-05-17 1993-12-16 ベイラー カレッジ オブ メディシン 成長抑制因とガンおよび細胞増殖性疾患措置法
IT1271301B (it) * 1994-12-20 1997-05-27 Indena Spa Calconi naturali e sintetici e loro esteri ad attivita' antiproliferativa nei tumori dell'utero,dell'ovaio e del seno e formulazioni che li contengono
US5525625A (en) * 1995-01-24 1996-06-11 Warner-Lambert Company 2-(2-Amino-3-methoxyphenyl)-4-oxo-4H-[1]benzopyran for treating proliferative disorders

Also Published As

Publication number Publication date
AU7648800A (en) 2001-04-10
HK1043997B (zh) 2003-08-15
DE60001850T2 (de) 2003-12-11
AU775083B2 (en) 2004-07-15
GB9920908D0 (en) 1999-11-10
ATE235480T1 (de) 2003-04-15
EP1212311A1 (en) 2002-06-12
RU2002108567A (ru) 2004-01-10
SE1212311T3 (pl) 2003-05-06
CA2382112A1 (en) 2001-03-15
WO2001017984A1 (en) 2001-03-15
KR100819574B1 (ko) 2008-04-04
US6767916B2 (en) 2004-07-27
HUP0202581A3 (en) 2003-07-28
CN1371370A (zh) 2002-09-25
DE60001850D1 (de) 2003-04-30
NO20021048D0 (no) 2002-03-01
HK1043997A1 (en) 2002-10-04
PT1212311E (pt) 2003-08-29
JP2003508523A (ja) 2003-03-04
RU2266291C2 (ru) 2005-12-20
US20020161036A1 (en) 2002-10-31
ES2191643T3 (es) 2003-09-16
CN1142927C (zh) 2004-03-24
HUP0202581A2 (hu) 2002-11-28
KR20020030800A (ko) 2002-04-25
NO20021048L (no) 2002-05-03
PL353245A1 (pl) 2003-11-03
SK3102002A3 (en) 2003-10-07
SE1212311T5 (pl) 2003-06-10
CZ2002786A3 (cs) 2002-06-12
EP1212311B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
DK1212311T3 (da) Chalconcumariner
PT1413582E (pt) Pirrolobenzodiazepinas dimericas
AU2795000A (en) Epothilone derivatives and their use as antitumor agents
EA200300595A1 (ru) Соединения пиперазинилпиразинов в качестве антагонистов серотонин 5-ht2 рецептора
AU2002246728A1 (en) Carboline derivatives
HK1088845A1 (en) Use of parthenolide derivatives as antileukemic and cytotoxic agents
ATE346067T1 (de) Carbolinderivate
ATE300541T1 (de) Pyrazolopyridinderivate
MXPA03002911A (es) Compuestos quimicos.
MXPA02012076A (es) Compuestos quimicos.
AU2315288A (en) Cell growth inhibitors and methods of treating cancer and cell proliferative diseases
MY133969A (en) Indoloquinazolinones
HK1045990A1 (en) Novel derivatives and analogues of galanthamin.
ATE259813T1 (de) Triazolopyrimidinderivate
DE60112960D1 (de) Kondensierte pyridoindolderivate
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
TR200102742T2 (tr) Rezorsinol türevleri
AU2001263278A1 (en) Cyclic gmp-specific phosphodiesterase inhibitors
ATE274515T1 (de) Pyrazolopyridinderivate
MXPA03003971A (es) Derivados de indol como inhibidores de pde5.
SE9904128D0 (sv) Novel compounds
MXPA02012472A (es) Compuestos quimicos.
AU2002359762A1 (en) Luminacin analogs and uses thereof
SE0004244D0 (sv) Novel compounds and their use
AP2001002047A0 (en) Isoquinoliness as urokinase inhibitors.